AbCellera Biologics Inc. (ABCL)

USD 2.69

(-3.58%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 1.48 Billion 1.54 Billion 1.31 Billion 1 Billion 23.48 Million 21.49 Million
Total Current Assets 871.98 Million 1.02 Billion 929.8 Million 813.32 Million 12.64 Million 15.16 Million
Cash And Short Term Investments 760.58 Million 886.48 Million 722.97 Million 594.11 Million 7.55 Million 10.44 Million
Cash and Cash Equivalents 133.32 Million 386.53 Million 476.14 Million 594.11 Million 7.55 Million 10.44 Million
Short Term Investments 627.26 Million 499.95 Million 246.83 Million - - -
Net Receivables 64.38 Million 38.59 Million 160.57 Million 213.23 Million 4.37 Million 4.16 Million
Inventory 1.1 Million 1.53 Million 1.67 Million 1.4 Million 163 Thousand 1.00
Other Current Assets 20.91 Million 75.41 Million 21.24 Million 5.97 Million 1.81 Million 550.33 Thousand
Total Non-Current Assets 616.1 Million 515.41 Million 388.76 Million 192.21 Million 10.84 Million 6.32 Million
Net PPE 287.69 Million 217.25 Million 111.61 Million 17.92 Million 8.47 Million 6.32 Million
Good Will And Intangible Assets 168.23 Million 179.3 Million 196.19 Million 146.65 Million - -
Good Will 47.8 Million 47.8 Million 47.8 Million 31.5 Million - -
Intangible Assets 120.42 Million 131.5 Million 148.39 Million 115.15 Million - -
Long-Term Investments 65.93 Million 72.52 Million 50.31 Million 19.24 Million - -
Tax Assets - 5.3 Million 7.4 Million 5.89 Million - -
Other Non Current Assets 94.24 Million 41.03 Million 23.23 Million 2.49 Million 2.36 Million -
Other Assets - - - - - -
Total Liabilities 335.77 Million 307.63 Million 292.83 Million 175.02 Million 13.23 Million 9.88 Million
Total Current Liabilities 119.01 Million 118.32 Million 120.67 Million 103.49 Million 7.89 Million 6.43 Million
Account Payables 25.5 Million 33.15 Million 32.01 Million 20 Million 1.64 Million 1.51 Million
Tax Payables - - 35.68 Million 36.15 Million - -
Short Term Debt 6.15 Million 5.58 Million 3.65 Million 190 Thousand 2.88 Million 2.53 Million
Deferred Revenue 26.07 Million 21.61 Million 7.53 Million 6.58 Million 3.23 Million 2.33 Million
Other Current Liabilities 61.27 Million 57.97 Million 77.47 Million 76.7 Million 129.34 Thousand 50.11 Thousand
Total Non Current Liabilities 216.76 Million 189.31 Million 172.16 Million 71.53 Million 5.34 Million 3.44 Million
Long-Term Debt 71.22 Million 76.67 Million 36.41 Million 5.91 Million 4 Million 911.22 Thousand
Deferred Revenue Non Current 104.11 Million 60.31 Million 60.75 Million 25.89 Million 1.33 Million 2.26 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 10.81 Million 19.14 Million 37.61 Million 13.57 Million -1.36 Million 277.13 Thousand
Other Liabilities - - - - - -
Total Equity 1.15 Billion 1.23 Billion 1.02 Billion 830.5 Million 10.25 Million 11.6 Million
Stock Holders Equity 1.15 Billion 1.23 Billion 1.02 Billion 830.5 Million 10.25 Million 11.6 Million
Common Stock 753.19 Million 734.36 Million 722.43 Million 710.38 Million 5.12 Million 5.07 Million
Retained Earnings 279.78 Million 426.18 Million 267.66 Million 114.2 Million -4.71 Million -2.5 Million
Accumulated other comprehensive income -1.72 Million -1.39 Million 280 Thousand - - -1.55 Million
Common Stock Equity 1.15 Billion 1.23 Billion 1.02 Billion 830.5 Million 10.25 Million 11.6 Million
Capital Lease Obligation 77.38 Million 76.67 Million 36.41 Million 3.71 Million 3.06 Million -
Total Investments 693.2 Million 572.47 Million 297.14 Million 19.24 Million - -
Total Debt 77.38 Million 82.25 Million 36.41 Million 6.1 Million 6.89 Million 3.44 Million
Net Debt -55.94 Million -304.27 Million -439.72 Million -588.01 Million -661.93 Thousand -7 Million

Balance Sheet Charts